<DOC>
	<DOCNO>NCT01650792</DOCNO>
	<brief_summary>The main purpose study determine noninvasive marker brain involvement Chagas disease . In subgroup patient high intensity transient signal ( HITS ) transcranial Doppler monitorization , investigator aim determine efficacy safety aspirin prevent microembolization patient previous history stroke . Specific aim list bellow : ( 1 ) establish brain magnetic resonance image marker stroke risk patient Chagasic heart failure ( HF ) ; ( 2 ) determine whether biomarkers predict stroke risk patient Chagasic HF ; ( 3 ) evaluate efficacy antiplatelet treatment decrease microembolization rate patient Chagasic HF .</brief_summary>
	<brief_title>Clinical Assessment , Neuroimaging Immunomarkers Chagas Disease Study ( CLINICS )</brief_title>
	<detailed_description>Stroke enormous international public health concern , particularly develop world limit resource available provide age population . One main contributor stroke incidence highly prevalent Chagas disease , parasitic infection affect estimate 18 million individual major cause heart failure Latin America . Chagas disease conveys stroke risk two establish mechanism : structural cardiac disease chronic inflammation . Although inflammation associate increase risk ischemic stroke poorer outcome , role largely link atherogenesis . Chronic inflammation result endothelial dysfunction stimulate hemostatic system , increase systemic fibrin production platelet activation . Brain atrophy also associate chronic inflammation . Adults , young old , develop secondary cardiomyopathy Chagas therefore high risk cardioembolism neurodegeneration . Stroke patient usually survive , leave significant disability affect health status , productivity , quality life . These factor impact caregiver well . Thus , social economic consequence stroke vast . During R21 plan grant period , able establish collaborative infrastructure research group Brazil United States collect preliminary data . We find association Chagas disease stroke independent cardiomyopathy . Cognitive impairment brain atrophy also associate Chagas disease independently cardiomyopathy . Biomarkers orosomucoid , neprilysin , interleukin-6 ( IL-6 ) matrix metalloproteinase-9 ( MMP-9 ) identify diagnostic therapeutic target Chagas disease . As part phase , address three specific aim : ( 1 ) establish brain magnetic resonance image marker stroke risk patient Chagasic congestive heart failure ( CM ) ; ( 2 ) determine whether biomarkers predict stroke risk patient Chagasic CM ; ( 3 ) evaluate efficacy antiplatelet treatment decrease microembolization rate patient Chagasic CM . The long-term goal project establish non-invasive method stroke risk stratification prediction stroke outcome patient Chagas disease . This work also facilitate development novel anti-trypanosomal , anti-inflammatory , antithrombotic strategy stroke prevention management Brazil .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Chagas Disease</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>Diagnosis heart failure accord Framingham criterion Informed consent Age 18 year Patients history untreated malignancy ( except local skin cancer ) Ischemic stroke ( determine use Questionnaire Verifying StrokeFree Status ( QVSFS ) Patients renal dialysis endstage hepatic dysfunction Acute infection/inflammation ( Temperature &gt; 101.5 F , and/or WBC &gt; 15 , 000 ) Inability obtain informed consent patient next kin Anticoagulant use ( warfarin heparin )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Chagas disease</keyword>
	<keyword>Heart failure</keyword>
	<keyword>Stroke</keyword>
	<keyword>Dementia</keyword>
</DOC>